Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):146-155. Epub 2018 May 24.

Abstract

In the past years the peripheral nervous system (PNS) involvement in systemic lupus erythematosus (SLE) has received little attention despite its potential significant impact. The true prevalence of PNS in SLE reported in studies is variable and strongly influenced by American College of Rheumatology (ACR) case definition that includes seven PNS manifestations (acute inflammatory demyelinating polyradiculoneuropathy, autonomic disorder, mononeuropathy, myasthenia gravis, cranial neuropathy, plexopathy and polyneuropathy). Other peripheral manifestations, such as chronic inflammatory demyelinating polyradiculoneuropathy and small fibre neuropathy, not included in the ACR nomenclature, have not been well characterised in SLE. The aim of this review is to focus on epidemiology, pathogenesis, diagnosis and clinical features of all possible different expressions of PNS involvement in SLE, with the final objective to profile the patient's clinical characteristics.

Publication types

  • Review

MeSH terms

  • Humans
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Lupus Erythematosus, Systemic* / immunology
  • Peripheral Nervous System / physiopathology*
  • Peripheral Nervous System Diseases* / complications
  • Peripheral Nervous System Diseases* / drug therapy
  • Peripheral Nervous System Diseases* / immunology